Gabrielle Haeberli
Overview
Explore the profile of Gabrielle Haeberli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
185
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rueff F, Przybilla B, Bilo M, Muller U, Scheipl F, Seitz M, et al.
PLoS One
. 2013 May;
8(5):e63233.
PMID: 23700415
Background: Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Objective: Our aim was to evaluate the association of baseline serum tryptase concentration (BTC)...
2.
Rueff F, Przybilla B, Bilo M, Muller U, Scheipl F, Aberer W, et al.
J Allergy Clin Immunol
. 2010 Jun;
126(1):105-11.e5.
PMID: 20542320
Background: Severe side effects during venom immunotherapy (VIT) are associated with a variety of risk factors. Objective: Our aim was to evaluate the association of baseline serum tryptase concentration (BTC)...
3.
Rueff F, Przybilla B, Bilo M, Muller U, Scheipl F, Aberer W, et al.
J Allergy Clin Immunol
. 2009 Nov;
124(5):1047-54.
PMID: 19895993
Background: Severe anaphylaxis to honeybee or vespid stings is associated with a variety of risk factors, which are poorly defined. Objective: Our aim was to evaluate the association of baseline...
4.
Muller U, Haeberli G
Curr Allergy Asthma Rep
. 2008 Dec;
9(1):64-70.
PMID: 19063827
Mastocytosis is a rare disease characterized by an elevated whole body mast cell number. Anaphylaxis is a severe, generalized hypersensitivity reaction with rapid onset. The problem of anaphylaxis and mastocytosis...
5.
Muller U, Jutel M, Reimers A, Zumkehr J, Huber C, Kriegel C, et al.
J Allergy Clin Immunol
. 2008 Oct;
122(5):1001-1007.e4.
PMID: 18845330
Background: H1 antihistamines increase safety during allergen-specific immunotherapy and might influence the outcome because of immunoregulatory effects. Objective: We sought to analyze the influence of 5 mg of levocetirizine (LC)...
6.
Muller U, Haeberli G
J Allergy Clin Immunol
. 2005 Mar;
115(3):606-10.
PMID: 15753911
Background: Beta-blockers may aggravate anaphylactic reactions and interfere with treatment. There is therefore concern about their use in patients who have a history of anaphylaxis or are on allergen immunotherapy....